Skip to main content
. 2018 Oct 10;22(2):157–165. doi: 10.1007/s40477-018-0322-5

Table 1.

Patients’ characteristics

Case no. Age (years) Gender BMI (kg/m2) Diabetes Alcohol intake Oral contraceptive use (duration) Chronic hepatic disease Mode of discovery Single or multiple nodules Other
1 51 F 23.9 No No Yes (6 years) No Abdominal pain Multiple NA
2 31 F 28.3 No No Yes (12 years) NAFLD Abdominal pain Multiple NA
3 33 F 24.7 No No Yes (15 years) No Incidental Multiple NA
4 34 M 25.9 No No NA No Abnormal LFT Single Prior use of anabolic steroids
5 38 F 22.7 No No No No Incidental Single NA
6 29 F 20.3 No No No No Incidental Single NA
7 28 M 28.1 No No NA NAFLD Incidental Single NA
8 41 M 25 No No NA NAFLD Incidental Single GSD
9 36 F > 30 No No Yes (10 years) NAFLD Incidental Multiple NA
10 51 F 31.2 Yes No Yes (20 years) NAFLD Incidental Single NA
11 39 F 24.1 No No Yes (20 years) No Abnormal LFT Multiple NA
12 40 F 20.3 No No Yes (10 years) No Incidental Multiple NA
13 43 F 22 No No No No Incidental Single NA
14 44 F 25 No No Yes (20 years) No Incidental Single NA
15 31 F 26.8 No No Yes (5 years) NAFLD Abdominal pain Multiple NA
16 37 F 23.8 No No Yes (1.5 years) No Incidental Single NA
17 29 F 20.3 No No No NAFLD Abnormal LFT Single GSD
18 31 F 22.3 No No No No Abnormal LFT Single GSD
19 31 F 20.8 No No Yes (2.5 years) NAFLD Incidental Single NA

BMI body mass index, NA not applicable, NAFLD non-alcoholic fatty liver disease, LFT liver function tests, GSD glycogen storage disease